Four-Strain Flu Vaccine Gains Traction With Sanofi’s sBLA Filing
This article was originally published in The Pink Sheet Daily
Executive Summary
CDC advisory committee to discuss the vaccines at its Oct. 25 meeting; Sanofi’s application for a quadrivalent flu vaccine comes eight months after FDA approved MedImmune’s quadrivalent and seven months after GSK’s filing.